Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model.

Antimicrob Agents Chemother

Institut National de la Santé et de la Recherche Médicale, Unité 13, Hôpital Bichat-Claude-Bernard, Paris, France.

Published: September 1995

In the dexamethasone-treated rat model of cryptosporidiosis, paromomycin was effective at a dosage of 50 mg/kg/day or more for ileal infection and 200 mg/kg/day or more for cecal infection. At 1 and 3 weeks after treatment, a persistent infection was demonstrated in all rats. These results confirm the anticryptosporidial activity of paromomycin and underscore the limitations of this compound because of its potential toxicity at such high dosages and its inability to eradicate the infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC162902PMC
http://dx.doi.org/10.1128/AAC.39.9.2155DOI Listing

Publication Analysis

Top Keywords

dexamethasone-treated rat
8
rat model
8
evaluation high-dose
4
high-dose regimen
4
regimen paromomycin
4
paromomycin cryptosporidiosis
4
cryptosporidiosis dexamethasone-treated
4
model dexamethasone-treated
4
model cryptosporidiosis
4
cryptosporidiosis paromomycin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!